July 27 (Reuters) – Boston Scientific's board has approved a new company-wide restructuring plan aimed at cutting costs and to better position the company for future growth, the medical device maker
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)